Clinical Trial Update: Comparison of Empaglifozin and Vildagliptin in Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial compared empagliflozin and vildagliptin in adults with type 2 diabetes and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)
• Vildagliptin (vildagliptin)

Snippet

Sponsor: Getz Pharma | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED